Measuring Adult Stem Cell Effectiveness
Tuesday, March 28, 2006 - Stem Cell Guru
The majority of doctors still beleive that unless they can actually see accurately measureable improvements in heart function then any improvement resulting from a patient receiving adult stem cell therapy for heart disease is more of a feel good factor than medical effect.
Additionally, the number of stem cells required for any treatment to be effective is debatable. If only there was a scientific way to measure the effect that implanted stem cells had on heart function. Researchers at Cordis, a subsidiary of Johnson & Johnson, is paving the way for the pioneers to both accurately deliver stem cells via catheter and also measure the effectiveness through advanced 3-D imaging of the heart.
Cordis has developed two breakthrough products.
The NOGA(R) Cardiac Navigation System is the most advanced technology currently vailable on the market to create highly precise, three-dimensional images of the heart. Based on these images, physicians are able to accurately identify tissue that could benefit from a variety of targeted therapies.
The MYOSTAR(TM) Injection Catheter is not yet commercially available in the United States and is used only under investigational protocols.
Read the Press Release from Cordis: NOGA(R) Cardiac Navigation System from Biologics Delivery Systems Group, Cordis Corporation, Helped Researchers Deliver Stem Cells to the Heart
Additionally, the number of stem cells required for any treatment to be effective is debatable. If only there was a scientific way to measure the effect that implanted stem cells had on heart function. Researchers at Cordis, a subsidiary of Johnson & Johnson, is paving the way for the pioneers to both accurately deliver stem cells via catheter and also measure the effectiveness through advanced 3-D imaging of the heart.
Cordis has developed two breakthrough products.
The NOGA(R) Cardiac Navigation System is the most advanced technology currently vailable on the market to create highly precise, three-dimensional images of the heart. Based on these images, physicians are able to accurately identify tissue that could benefit from a variety of targeted therapies.
The MYOSTAR(TM) Injection Catheter is not yet commercially available in the United States and is used only under investigational protocols.
Read the Press Release from Cordis: NOGA(R) Cardiac Navigation System from Biologics Delivery Systems Group, Cordis Corporation, Helped Researchers Deliver Stem Cells to the Heart
Site Feed
0 Comments:
Post a Comment
<< Home